1. Home
  2. ORRF vs FTRE Comparison

ORRF vs FTRE Comparison

Compare ORRF & FTRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Orrstown Financial Services Inc

ORRF

Orrstown Financial Services Inc

HOLD

Current Price

$35.11

Market Cap

699.5M

Sector

Finance

ML Signal

HOLD

Logo Fortrea Holdings Inc.

FTRE

Fortrea Holdings Inc.

HOLD

Current Price

$13.67

Market Cap

829.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ORRF
FTRE
Founded
1919
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
699.5M
829.3M
IPO Year
1995
2023

Fundamental Metrics

Financial Performance
Metric
ORRF
FTRE
Price
$35.11
$13.67
Analyst Decision
Buy
Buy
Analyst Count
1
9
Target Price
$42.00
$14.06
AVG Volume (30 Days)
80.6K
1.5M
Earning Date
04-21-2026
05-05-2026
Dividend Yield
3.29%
N/A
EPS Growth
182.43
N/A
EPS
1.12
N/A
Revenue
$37,144,000.00
$2,723,400,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$3.15
$3.09
P/E Ratio
$32.06
N/A
Revenue Growth
36.00
1.00
52 Week Low
$29.31
$3.97
52 Week High
$40.72
$18.67

Technical Indicators

Market Signals
Indicator
ORRF
FTRE
Relative Strength Index (RSI) 38.51 59.26
Support Level $34.51 $8.85
Resistance Level $35.99 $18.26
Average True Range (ATR) 0.87 0.82
MACD -0.21 0.07
Stochastic Oscillator 11.81 54.77

Price Performance

Historical Comparison
ORRF
FTRE

About ORRF Orrstown Financial Services Inc

Orrstown Financial Services Inc is a financial holding company. Through its subsidiaries, it operates in the community banking segment and engages in lending activities, including commercial, residential, commercial mortgages, construction, municipal, and various forms of consumer lending and deposit services, including checking, savings, time, and money market deposits. The Group also provides fiduciary, investment advisory, insurance, and brokerage services. It offers services to individuals, professionals, small businesses, and other enterprises across different locations in the United States through its branch network and client service centers.

About FTRE Fortrea Holdings Inc.

Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.

Share on Social Networks: